课题基金 / 基金详情

项目摘要

项目成果

CHRISTOPHER L. BERGER的其他基金

相关文献

中文摘要
翻译
该提案的最终目标是检查平滑内特定位置的构象变化, 肌肉肌球蛋白使用内在色氨酸荧光。平滑肌肌球蛋白构建体将在基因上 经工程改造以在所需的感兴趣位点含有单个色氨酸或一对色氨酸, 将提供独特的内在荧光信号,报告局部构象和结构变化, 对核苷酸结合、ATP水解、肌动蛋白结合和杠杆臂运动的反应。这些实验 是对该领域正在进行的结构研究的补充,使我们能够明确地测试预测 在收缩周期的关键步骤中, 肌球蛋白因此,我们将能够将肌球蛋白的结构变化与功能后果相关联, 它与某些心血管疾病直接相关。例如,FHC(家族性肥大性 心肌病)是一种遗传性的,通常是致命的疾病,由体内关键结构的点突变引起。 肌球蛋白对于其作为分子马达的正常功能至关重要。我们将研究结构性变化, 肌球蛋白的分子区域直接受到FHC突变的影响。这将导致更好的 了解疾病,从而获得更好的治疗方案。因此,该提案提供了一个 一个独特的机会来批判性地测试有关肌肉分子机制的基本问题, 收缩,以前没有其他光谱探针研究,结果 将对严重的疾病状态如FHC产生重要影响。
英文摘要
The ultimate goal of this proposal is to examine conformational changes at specific locations within smooth muscle myosin using intrinsic tryptophan fluorescence. Smooth muscle myosin constructs will be genetically engineered to contain either a single tryptophan or a pair of tryptophans at the desired site of interest, which will provide a unique intrinsic fluorescence signal reporting local conformational and structural changes in response to nucleotide binding, ATP hydrolysis, actin-binding, and lever arm movement. These experiments are complementary to the ongoing structural studies in the field, allowing us to explicitly test predictions about domain movements and structural rearrangements during critical steps in the contractile cycle smooth muscle myosin. Thus we will be able to correlate structural changes in myosin with functional consequences, which relates directly to certain cardiovascular disease. For example, FHC (familial hypertrophic cardiomyopathy) is an inherited, often lethal disease caused by point mutations at key structures within myosin critical to its proper functioning as a molecular motor. We will be examining structural changes in myosin in regions of the molecule directly impacted by mutations that underlie FHC. This will lead to a better understanding of the disease, and thus to better treatment options as well. Therefore, this proposal offers a unique opportunity to critically test fundamental questions about the molecular mechanism of muscle contraction that have not been previously accessible by other spectroscopic probe studies, and the results will have important implications for serious disease states such as FHC.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Nucleotide dependent intrinsic fluorescence changes of W29 and W36 in smooth muscle myosin.
平滑肌肌球蛋白中 W29 和 W36 的核苷酸依赖性内在荧光变化。
DOI: 10.1529/biophysj.104.044388
发表时间: 2004
期刊: Biophysical journal
影响因子: 3.4
作者: [vanDuffelen,Marilyn, Chrin,LynnR, Berger,ChristopherL]
通讯作者: Berger,ChristopherL
Structural rearrangements in the active site of smooth-muscle myosin.
平滑肌肌球蛋白活性位点的结构重排。
DOI: 10.1529/biophysj.105.059840
发表时间: 2005
期刊: Biophysical journal
影响因子: 3.4
作者: [Robertson,CIan, Gaffney2nd,DonaldP, Chrin,LynnR, Berger,ChristopherL]
通讯作者: Berger,ChristopherL
Kinetics of structural changes in the relay loop and SH3 domain of myosin.
肌球蛋白中继环和 SH3 结构域结构变化的动力学。
DOI: 10.1016/j.bbrc.2005.01.152
发表时间: 2005
期刊: Biochemical and biophysical research communications.
影响因子: --
作者: [vanDuffelen,Marilyn, Chrin,LynnR, Berger,ChristopherL]
通讯作者: Berger,ChristopherL
Switch I closure simultaneously promotes strong binding to actin and ADP in smooth muscle myosin.
Switch I 关闭同时促进平滑肌肌球蛋白中肌动蛋白和 ADP 的强结合。
DOI: 10.1074/jbc.m111.219014
发表时间: 2011
期刊: The Journal of biological chemistry
影响因子: --
作者: [Decarreau,JustinA, James,NicholasG, Chrin,LynnR, Berger,ChristopherL]
通讯作者: Berger,ChristopherL
Regulation of Axonal Transport by Tau
Regulation of Axonal Transport by Tau
Regulation of Axonal Transport by Tau
Tau-mediated regulation of axonal transport